3-36991692-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_014805.4(EPM2AIP1):​c.1386G>A​(p.Met462Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,612,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000013 ( 0 hom. )

Consequence

EPM2AIP1
NM_014805.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.541
Variant links:
Genes affected
EPM2AIP1 (HGNC:19735): (EPM2A interacting protein 1) The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.035217404).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPM2AIP1NM_014805.4 linkc.1386G>A p.Met462Ile missense_variant Exon 1 of 1 ENST00000322716.8 NP_055620.1 Q7L775

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPM2AIP1ENST00000322716.8 linkc.1386G>A p.Met462Ile missense_variant Exon 1 of 1 6 NM_014805.4 ENSP00000406027.1 Q7L775
EPM2AIP1ENST00000624586.1 linkc.387+189G>A intron_variant Intron 1 of 1 5 ENSP00000485091.1 A0A096LNL1
EPM2AIP1ENST00000623924.1 linkc.62+1186G>A intron_variant Intron 1 of 2 5 ENSP00000485489.1 A0A096LPB0

Frequencies

GnomAD3 genomes
AF:
0.0000657
AC:
10
AN:
152158
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000525
AC:
13
AN:
247546
Hom.:
0
AF XY:
0.0000372
AC XY:
5
AN XY:
134394
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000262
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000178
Gnomad OTH exome
AF:
0.000333
GnomAD4 exome
AF:
0.0000130
AC:
19
AN:
1460668
Hom.:
0
Cov.:
33
AF XY:
0.00000826
AC XY:
6
AN XY:
726680
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000269
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000270
Gnomad4 OTH exome
AF:
0.0000663
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152158
Hom.:
0
Cov.:
33
AF XY:
0.0000942
AC XY:
7
AN XY:
74340
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.000106
ExAC
AF:
0.0000248
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 07, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.1386G>A (p.M462I) alteration is located in exon 1 (coding exon 1) of the EPM2AIP1 gene. This alteration results from a G to A substitution at nucleotide position 1386, causing the methionine (M) at amino acid position 462 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
14
DANN
Benign
0.91
DEOGEN2
Benign
0.016
T
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.68
T
M_CAP
Benign
0.0036
T
MetaRNN
Benign
0.035
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.54
N
REVEL
Benign
0.038
Sift
Benign
0.18
T
Sift4G
Benign
0.35
T
Polyphen
0.0010
B
Vest4
0.13
MutPred
0.33
Gain of catalytic residue at L467 (P = 0.0668);
MVP
0.20
MPC
0.62
ClinPred
0.043
T
GERP RS
3.8
Varity_R
0.15
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs769400518; hg19: chr3-37033183; API